Introduction

In 2026 London’s hospitality scene is seeing a deliberate, more measured embrace of CBD on menus. From heritage plant‑based cafés to buzzy cocktail bars, venues are introducing CBD‑forward drinks that sit alongside expanded no/low‑alcohol options. This wave is being driven less by novelty and more by regulation, product reformulation and shifting consumer priorities — especially the Food Standards Agency’s provisional acceptable daily intake (ADI) of 10 mg CBD per day. Below we set out what’s trending, why it matters, examples from the city and what to expect next.

What’s trending

Several clear patterns are emerging across London venues in 2026:

• Curated CBD menus: Established operators such as Farmacy and The Cocktail Club are formally rolling out CBD‑infused drinks, ranging from CBD lattes to mocktails and low‑ABV serves.
• Measured dosing in on‑trade settings: Dedicated CBD cocktail pop‑ups opening this year are serving cocktails and mocktails with measured CBD doses; reporting from early events cites serves around 15 mg per drink.
• Reformulation to meet 10 mg guidance: Major ready‑to‑drink brands are reducing per‑serve CBD to 10 mg to align with the FSA provisional ADI — names reported in the market include Goodrays and Trip.
• No/low‑alcohol synergy: The ongoing expansion of no/low drinks menus creates a natural home for non‑intoxicating CBD mocktails and low‑ABV serves.
• Brand‑first consumer behaviour: Shoppers and diners increasingly choose by brand, flavour and functional positioning rather than single‑ingredient claims — a shift prompting venue collaborations with trusted CBD suppliers.

Why this matters

The 10 mg provisional ADI set out by the FSA is the headline driver. While the guidance is framed as a safe daily intake benchmark rather than a hard prohibition, it has immediate practical consequences for manufacturers and hospitality operators:

• Product developers are reworking formulations to keep per‑serve CBD at or below 10 mg — a move that helps avoid consumer confusion about cumulative intake across multiple servings in a day.
• The on‑trade (bars, cafés, restaurants) prefers predictable, calibrated ingredients; measured dosing reduces operational risk and improves consistency for front‑of‑house teams.
• Where brands cannot economically deliver the same sensory profile at 10 mg, some manufacturers are pivoting towards mineral‑led or botanical functional blends (for example magnesium or calming adaptogen blends) to preserve the product story while reducing CBD content — a trend reported by The Grocer as reshaping both formulations and on‑trade offers.

Examples from London’s 2026 rollout

Several operators are notable for how they’re combining creativity with compliance.

Farmacy — CBD revival with pedigree

Farmacy is reintroducing CBD‑forward drinks in 2026 after a history of menu innovation — previously featuring CBD cocktails, smoothies and even a CBD 'High Tea'. Their approach this year is careful: measured servings, clear menu labelling and options that pair CBD with low‑alcohol bases and herbal flavours to maximise enjoyment without over‑reliance on high per‑serve CBD.

The Cocktail Club — mainstreaming CBD mocktails

The Cocktail Club is trialling CBD‑enhanced mocktails across selected venues as part of an expanded low/no programme. Expect balanced flavour profiles where the CBD component complements citruses, botanical bitters and fermented tea bases rather than dominating them.

Dedicated pop‑ups and experimental concepts

In 2026 a dedicated CBD cocktail pop‑up launched in London, serving measured cocktails and mocktails; early reports indicate some serves averaged around 15 mg of CBD at events. Those serves reflect a tension: experimental hospitality often errs higher to showcase a noticeable effect, while current FSA guidance nudges operators toward single‑serve caps at 10 mg. Such pop‑ups are helping the trade understand consumer responses to both sensory cues and dose sizes.

Branded ingredients and consistency

Operators increasingly partner with branded CBD ingredients to guarantee consistent dosing and flavour. For venues wanting a measured approach behind the bar, practical tools include measured drops and water‑soluble enhancers that simplify portioning — for example, a drinks enhancer designed for bars can make it easier to craft compliant serves while maintaining reliable taste. If you’re experimenting at home or in a small café, measured tinctures such as a 1000 mg cold‑pressed oil can be used carefully to portion consistent microdoses.

Examples of products that venues or consumers may encounter include the CBD Drinks Enhancer, and specialty coffee collaborations such as Cannacoffee Original CBD Coffee (Ground), Cannacoffee Original CBD Coffee (Pods) and Cannacoffee Original CBD Coffee (Whole Bean). For operators and discerning consumers who want a versatile base oil, the Wylde Natural Cold‑Pressed Drops 1000 mg CBD Oil (10 ml) is another option for careful, measured dosing.

Future outlook — what operators and consumers should expect

Looking ahead through 2026 and beyond, several likely developments will shape how CBD appears on London menus:

• Tighter portioning and clearer labelling: Venues will standardise per‑serve CBD amounts and communicate cumulative daily intake to guests.
• Collaborative branded offers: Partnerships between venues and trusted CBD suppliers will accelerate, as operators seek turnkey, lab‑tested solutions that support consistent flavour and dose.
• Functional hybrids: Where CBD is reduced, expect more magnesium,anine or botanical blends to appear alongside microdoses of CBD — preserving a functional story while complying with intake guidance.
• Low/no‑alcohol ecosystems: CBD mocktails and low‑ABV serves will become a standard part of balanced menus, appealing to guests prioritising presence, flavour and moderation.

For consumers, the shift to brand‑first decision making means that provenance, lab transparency and flavour will increasingly determine which CBD drinks succeed. For operators, clear communication and measured dosing will be central to building trust and repeat custom.

Conclusion

London’s 2026 CBD rollout is less a free‑for‑all and more a calibrated reintegration. With Farmacy and The Cocktail Club bringing measured CBD drinks back into venues, experimental pop‑ups testing consumer appetite, and manufacturers reformulating to align with the FSA’s provisional 10 mg guidance, the market is maturely responding to both regulation and consumer preference. Expect to find well‑labelled CBD lattes, mocktails and low‑ABV serves that privilege flavour, consistency and clear dosing — and a hospitality landscape where trusted branded formulations help bridge the gap between curiosity and everyday use.

Note: The FSA’s 10 mg provisional guidance is shaping industry practice. This article discusses product and menu trends and does not offer medical advice. If in doubt about CBD use, consumers should consult a healthcare professional.